Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study.

Lamb, Christopher A; Sebastian, Shaji; Kent, Alexandra J; Segal, Jonathan P; Gonzalez, Haidee A; Brookes, Matthew J; Mehta, Shameer J; Subramanian, Sreedhar; Bhala, Neeraj; Hicks, Lucy C; Conley, Thomas E; Patel, Kamal V; Walker, Gareth J; Kennedy, Nicholas A

Lamb, Christopher A; Sebastian, Shaji; Kent, Alexandra J; Segal, Jonathan P; Gonzalez, Haidee A; Brookes, Matthew J; Mehta, Shameer J; Subramanian, Sreedhar; Bhala, Neeraj; Hicks, Lucy C; Conley, Thomas E; Patel, Kamal V; Walker, Gareth J; Kennedy, Nicholas A.

Lamb CA; Newcastle upon Tyne, UK.
Sebastian S; Hull, UK.
Kent AJ; London, UK.
Segal JP; London, UK.
Gonzalez HA; Hull, UK.
Brookes MJ; Wolverhampton, UK.
Mehta SJ; London, UK.
Subramanian S; Liverpool, UK.
Bhala N; Birmingham, UK.
Hicks LC; London, UK.
Conley TE; Liverpool, UK.
Patel KV; London, UK.
Walker GJ; Torquay, UK.
Kennedy NA; Exeter, UK.

Aliment Pharmacol Ther ; 53(11): 1236-1240, 2021 06.

Article in English | MEDLINE | ID: covidwho-1219506

Subject(s)

COVID-19; Inflammatory Bowel Diseases; Cohort Studies; Humans; Inflammatory Bowel Diseases/complications; Inflammatory Bowel Diseases/drug therapy; Inflammatory Bowel Diseases/epidemiology; SARS-CoV-2; United Kingdom/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Europa Language: English Journal: Aliment Pharmacol Ther Journal subject: Pharmacology / Gastroenterology / Drug Therapy Year: 2021 Document Type: Article Affiliation country: Apt.16349

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google